
Australasian neurologists review the ‘new era’ of MS treatment
A recent collaboration between MS neurologists has brought together the latest information on treatments and best practice for

A recent collaboration between MS neurologists has brought together the latest information on treatments and best practice for

The NSW MS Research Network partnered recently with the Health-Science Alliance for a dinner meeting in Sydney. The

Bladder or bowel symptoms commonly occur in MS. The symptoms, including incontinence from the bladder or bowel, can

There are now over 110 genetic changes that are known to increase an individual’s susceptibility to MS. Current

It was announced on the 24th June that Dr Matthew Miles, Chief Executive Officer of MS Research Australia,

MS Research Australia’s International Research Review Board helps guide the strategy that leverages Australia’s strengths, to best contribute to the

Two articles published recently by Australian and international investigators using the MSBase database provide insight into several factors

Over the last few years, genetic studies that included thousands of people with MS from around the world

The pharmaceutical sponsor of Gilenya (fingolimod), Novartis, has this week reported one case of Progressive Multifocal Leukoencephalopathy (PML)